Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the U.S. Food and Drug ...

North Carolina, USA-based biotech BioCryst Pharmaceuticals on Friday announced it has signed a definitive agreement to sell ...

US biotech major Biogen today announced new data that reinforce the clinical impact of nusinersen across a broad spectrum of ...

Alphabet-founded biotech Calico Life Sciences has struck an exclusive licensing agreement with Chinese drugmaker Mabwell (SHA ...

US biotech Arbutus Biopharma (Nasdaq: ABUS) has reacquired the rights to its lead hepatitis B candidate, imdusiran (AB-729), ...

German biosimilars company Formycon has announced that its 2025/2029 corporate bond was significantly oversubscribed due to ...

German drugmaker Bayer (BAYN: DE) has renewed its partnership with China’s Tsinghua University for another three years, ...

Italian drugmaker Philogen has announced its decision to voluntarily withdraw the application for marketing authorization to ...

US pharma major Merck & Co has secured a key endorsement for its newly approved respiratory syncytial virus (RSV) prevention ...

Belgian pharma UCB today announced that the Phase III study investigating the safety and efficacy of adjunctive fenfluramine ...

In a significant showcase for investors, BeOne Medicines announced major advancements to its industry-leading oncology ...

Japanese drugmaker Chugai Pharmaceutical today revealed that it has filed a regulatory application with the Ministry of ...